MedTrace Logo

Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis

NCT00209859 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2005-09-21

No results posted yet for this study

Summary

To investigate whether cyclosporine, added to methotrexate and steroid, increases the possibility of inflammatory management early in the disease; furthermore to investigate the possible steroid-sparing effect of cyclosporine in patients with recently diagnosed rheumatoid arthritis.

Conditions

Interventions

DRUG

Methotrexate

DRUG

Intraarticular betamethasone

DRUG

Cyclosporine/placebo-cyclosporine

Sponsors & Collaborators

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Merete L Hetland, MD, PhD · Hvidovre Univervsity Hospital

  • Kim Hørslev-Petersen, MD, DSc · Rheumatism Hospital Graasten

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-10-31
Completion
2007-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00209859 on ClinicalTrials.gov